Advertisement
Advertisement
U.S. Markets close in 3 hrs 10 mins
Advertisement
Advertisement
Advertisement
Advertisement

Clarus Therapeutics Holdings, Inc. (CRXT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.3920-0.0156 (-3.83%)
As of 04:00PM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/24/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 331.2400
52 Week Low 30.3750
50-Day Moving Average 31.0040
200-Day Moving Average 33.5290

Share Statistics

Avg Vol (3 month) 313.49M
Avg Vol (10 day) 36.41M
Shares Outstanding 524.03M
Implied Shares Outstanding 6N/A
Float 819.68M
% Held by Insiders 110.68%
% Held by Institutions 156.24%
Shares Short (Apr 28, 2022) 4620.9k
Short Ratio (Apr 28, 2022) 40.02
Short % of Float (Apr 28, 2022) 41.76%
Short % of Shares Outstanding (Apr 28, 2022) 41.21%
Shares Short (prior month Mar 30, 2022) 4744.48k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin -291.02%
Operating Margin (ttm)-284.67%

Management Effectiveness

Return on Assets (ttm)-69.84%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)13.96M
Revenue Per Share (ttm)1.99
Quarterly Revenue Growth (yoy)88.00%
Gross Profit (ttm)11.24M
EBITDA -39.71M
Net Income Avi to Common (ttm)-40.2M
Diluted EPS (ttm)-26.0170
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)26.41M
Total Cash Per Share (mrq)1.07
Total Debt (mrq)42.27M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.78
Book Value Per Share (mrq)-1.17

Cash Flow Statement

Operating Cash Flow (ttm)-43.79M
Levered Free Cash Flow (ttm)-41.34M
Advertisement
Advertisement